Cargando…

Physical Functional Capacity and C-Reactive Protein in Schizophrenia

INTRODUCTION: Schizophrenia is a severe, debilitating mental disorder that affects both the physical health and the functional capacity of patients, causing great impairment throughout the life course. Although physical and cognitive impairments may represent different expressions of a single system...

Descripción completa

Detalles Bibliográficos
Autores principales:	Szortyka, Michele Fonseca Vieira, Cristiano, Viviane Batista, Ceresér, Keila Maria, Francesconi, Lenise Petter, Lobato, Maria Inês, Gama, Clarissa, Belmonte-de-Abreu, Paulo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4974248/ https://www.ncbi.nlm.nih.gov/pubmed/27547191 http://dx.doi.org/10.3389/fpsyt.2016.00131

Ejemplares similares

A controlled open clinical trial of the positive effect of a physical intervention on quality of life in schizophrenia
por: Cristiano, Viviane Batista, et al.
Publicado: (2023)

Differential Physical and Mental Benefits of Physiotherapy Program Among Patients With Schizophrenia and Healthy Controls Suggesting Different Physical Characteristics and Needs
por: Szortyka, Michele Fonseca, et al.
Publicado: (2021)

Resveratrol Supplementation in Schizophrenia Patients: A Randomized Clinical Trial Evaluating Serum Glucose and Cardiovascular Risk Factors
por: Zortea, Karine, et al.
Publicado: (2016)

Aerobic and Postural Strength Exercise Benefits in People with Schizophrenia
por: Szortyka, Michele Fonseca, et al.
Publicado: (2023)

Resveratrol Supplementation Did Not Improve Cognition in Patients with Schizophrenia: Results from a Randomized Clinical Trial
por: Zortea, Karine, et al.
Publicado: (2016)

Ketamine study: Protocol for naturalistic prospective multicenter study on subcutaneous ketamine infusion in depressed patients with active suicidal ideation
por: Anzolin, Ana Paula, et al.
Publicado: (2023)

Commentary: Physical Functional Capacity and C-Reactive Protein in Schizophrenia
por: Elliesen, Ruth, et al.
Publicado: (2018)

Inflammatory markers in outpatients with schizophrenia diagnosis in regular use of clozapine: a cross-sectional study
por: Cordova, Victor Hugo Schaly, et al.
Publicado: (2023)

Editorial: Gender dysphoria: Diagnostic issues, clinical aspects, and health promotion
por: Lobato, Maria Inês Rodrigues
Publicado: (2022)

Risk of neutropenia among clozapine users and non-users: results from 5,847 patients
por: Goldani, André Akira Sueno, et al.
Publicado: (2021)

Bleuler's Psychopathological Perspective on Schizophrenia Delusions: Towards New Tools in Psychotherapy Treatment
por: Arantes-Gonçalves, Filipe, et al.
Publicado: (2018)

Predicting Real-World Functioning in Schizophrenia: The Relative Contributions of Neurocognition, Functional Capacity, and Negative Symptoms
por: Yang, Zixu, et al.
Publicado: (2021)

Risk factors for violence among female forensic inpatients with schizophrenia
por: Wolf, Viviane, et al.
Publicado: (2023)

Gender Differences in the Psychopharmacological Treatment of Forensic In-Patients With Schizophrenia
por: Mayer, Juliane, et al.
Publicado: (2022)

A Perspective on a Possible Relation Between the Psychopathology of the Schizophrenia/Schizoaffective Spectrum and Unconjugated Bilirubin: A Longitudinal Protocol Study
por: Gama Marques, João, et al.
Publicado: (2018)

Recurrent Episodes of Paraphilic Behavior Possibly Associated With Olanzapine and Aripiprazole Treatment in a Patient With Schizophrenia
por: Stefanou, Maria-Ioanna, et al.
Publicado: (2020)

Predictors for Antipsychotic Dosage Change in the First Year of Treatment in Schizophrenia Spectrum and Bipolar Disorders
por: Ringen, Petter Andreas, et al.
Publicado: (2019)

Effect of Transcranial Direct Current Stimulation on Functional Capacity in Schizophrenia: A Study Protocol for a Randomized Controlled Trial
por: Narita, Zui, et al.
Publicado: (2017)

Increased Mortality in Schizophrenia Due to Cardiovascular Disease – A Non-Systematic Review of Epidemiology, Possible Causes, and Interventions
por: Ringen, Petter Andreas, et al.
Publicado: (2014)

The Anti-social Brain in Schizophrenia: A Role of CaMKII?
por: El Rawas, Rana, et al.
Publicado: (2022)

Disembodied Language in Early-Onset Schizophrenia
por: Zakowicz, Przemysław, et al.
Publicado: (2022)

Physical and Sociodemographic Features Associated With Quality of Life Among Transgender Women and Men Using Gender-Affirming Hormone Therapy
por: Silva, Eliane D., et al.
Publicado: (2021)

Revisiting the Role of Eotaxin-1/CCL11 in Psychiatric Disorders
por: Teixeira, Antonio L., et al.
Publicado: (2018)

C-Reactive Protein as a Peripheral Biomarker in Schizophrenia. An Updated Systematic Review
por: Fond, Guillaume, et al.
Publicado: (2018)

Dysconnectivity in the Frontoparietal Attention Network in Schizophrenia
por: Roiser, Jonathan P., et al.
Publicado: (2013)

Noninvasive Brain Stimulation for Nicotine Dependence in Schizophrenia: A Mini Review
por: Ward, Heather Burrell, et al.
Publicado: (2022)

Acute paranoid schizophrenia relapsed inpatients present summer/ winter but not day/night changes in serum S100B concentrations
por: Armando L., Morera-Fumero, et al.
Publicado: (2021)

The Group of Treatment Resistant Schizophrenias. Heterogeneity in Treatment Resistant Schizophrenia (TRS)
por: Kinon, Bruce J.
Publicado: (2019)

Statistical Image Properties in Works from the Prinzhorn Collection of Artists with Schizophrenia
por: Henemann, Gudrun Maria, et al.
Publicado: (2017)

Disrupted-in-Schizophrenia 1 (DISC1) Overexpression and Juvenile Immune Activation Cause Sex-Specific Schizophrenia-Related Psychopathology in Rats
por: Uzuneser, Taygun C., et al.
Publicado: (2019)

Executive Functioning in Schizophrenia
por: Orellana, Gricel, et al.
Publicado: (2013)

Editorial: Smoking and Schizophrenia
por: Castle, David, et al.
Publicado: (2019)

Neurological Abnormalities in Recent-Onset Schizophrenia and Asperger-Syndrome
por: Hirjak, Dusan, et al.
Publicado: (2014)

Proteomics in Schizophrenia: A Gateway to Discover Potential Biomarkers of Psychoneuroimmune Pathways
por: Rodrigues-Amorim, Daniela, et al.
Publicado: (2019)

Clozapine prescription trends in Brazil in the last decade
por: Massuda, Raffael, et al.
Publicado: (2022)

Development of the Positive Emotions Program for Schizophrenia: An Intervention to Improve Pleasure and Motivation in Schizophrenia
por: Nguyen, Alexandra, et al.
Publicado: (2016)

COVID-19 in People With Schizophrenia: Potential Mechanisms Linking Schizophrenia to Poor Prognosis
por: Mohan, Mohapradeep, et al.
Publicado: (2021)

Genetics, Cognition, and Neurobiology of Schizotypal Personality: A Review of the Overlap with Schizophrenia
por: Ettinger, Ulrich, et al.
Publicado: (2014)

Cognitive Impairment in Bipolar Disorder and Schizophrenia: A Systematic Review
por: Vöhringer, Paul A., et al.
Publicado: (2013)

Imaging Violence in Schizophrenia: A Systematic Review and Critical Discussion of the MRI Literature
por: Fjellvang, Maria, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_p16a0bicemel1dvh2g7ul2l1jp